학술논문

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Document Type
Artikel
Source
The Journal of antimicrobial chemotherapy. 71(4):1056-1062
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1460-2091